NASDAQ:PRNB - Principia Biopharma Price Target & Analyst Ratings

$40.83
+0.81 (+2.02 %)
(As of 07/17/2019 04:00 PM ET)
Today's Range
$40.09
Now: $40.83
$41.81
50-Day Range
$29.26
MA: $34.62
$40.44
52-Week Range
$22.00
Now: $40.83
$41.48
Volume3,715 shs
Average Volume184,102 shs
Market Capitalization$974.61 million
P/E Ratio72.96
Dividend YieldN/A
BetaN/A

Analyst Ratings

Principia Biopharma (NASDAQ:PRNB) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
6 Wall Street analysts have issued ratings and price targets for Principia Biopharma in the last 12 months. Their average twelve-month price target is $47.3333, suggesting that the stock has a possible upside of 15.93%. The high price target for PRNB is $55.00 and the low price target for PRNB is $42.00. There are currently 6 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $47.3333$43.50$43.50$34.00
Price Target Upside: 15.93% upside49.43% upside49.43% upside33.70% upside

Principia Biopharma (NASDAQ:PRNB) Consensus Price Target History

Principia Biopharma (NASDAQ:PRNB) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/1/2019HC WainwrightInitiated CoverageBuy ➝ Buy$55.00HighView Rating Details
4/16/2019Stifel NicolausInitiated CoverageBuy ➝ Buy$45.00LowView Rating Details
3/21/2019Leerink SwannSet Price TargetBuy$42.00LowView Rating Details
10/9/2018Robert W. BairdInitiated CoverageOutperformHighView Rating Details
10/9/2018Wells Fargo & CoInitiated CoverageOutperform ➝ OutperformHighView Rating Details
10/9/2018Bank of AmericaInitiated CoverageBuy ➝ BuyHighView Rating Details
(Data available from 7/17/2017 forward)
This page was last updated on 7/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel